St. Jude Diversifies In Intra-Coronary Assessment Market With $90 Mil. Buy
This article was originally published in The Gray Sheet
Executive SummarySt. Jude Medical is upping the ante in the coronary lesion assessment space with the $90 million cash acquisition of LightLab Imaging
You may also be interested in...
Rights for Abbott to promote and distribute intravascular optical coherence tomography imaging and fractional flow reserve products from St. Jude Medical are added to an existing co-promotion pact between the firms.
One bright spot emerging in this otherwise lackluster economy is the market for optical imaging technologies. Optical imaging encompasses a wide array of current and emerging techniques that use light as the primary imaging modality to characterize local anatomy down to cellular and molecular levels.